Logo-jcvtr
Submitted: 22 Jun 2024
Revision: 26 Oct 2024
Accepted: 01 Jan 2025
ePublished: 18 Mar 2025
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Cardiovasc Thorac Res. 2025;17(1): 35-39.
doi: 10.34172/jcvtr.025.33237
  Abstract View: 104
  PDF Download: 100

Original Article

Clinical characteristics and surgical outcomes following cardiac myxoma resection

Nootan Hadiya ORCID logo, Madhur Kumar* ORCID logo, Rimy Parshad, Poorna Chandar, Anubhav Gupta

1 Department of Cardiothoracic & Vascular Surgery Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India
*Corresponding Author: Madhur Kumar, Email: madhurchandini@yahoo.com

Abstract

Introduction: Cardiac myxomas are the most common primary cardiac neoplasm (30-50%) with clinical incident of 0.5/ million population. Tranthoracic echocardiography remains the investigation of choice. Surgical excision is curative. The present study aims to analyze demographic and clinical characteristics as well as surgical outcomes in terms of mortality and recurrence of cardiac myxoma.

Methods: Thirty patients of cardiac myxoma who met the inclusion criteria during study period study period, January-2018 to April-2024 were included. Data was analyzed for demographic characteristics, echocardiographic findings of myxoma and associated valve lesion, associated valve surgery and survival outcome.

Results: Of all subjects, 83.33% presented with dyspnea. Majority of myxoma, 76.67% were attached to interatrial septum. Overall survival at 1- and 3- year was 91.23%. Recurrence free survival at 1-, 3- years and end of this study were 100%, 84.71% and 84.71% respectively. Myxomas with valvular incompetence are rare entity and there is paucity of data and evidences recommending concomitant valve intervention in such cases. There were no immediate peri-operative deaths, however, in contrast to other studies; surgical site infection was the most common post operative complication. Overall survival at 1- and 3- year was 91.23%. Recurrence free survival at 1-, 3- years and end of this study were 100%, 84.71% and 84.71% respectively. Recurrence occurred in first- and third-year following surgery.

Conclusion: Study highlights decent outcomes following cardiac myxoma resection. Case specific concomitant valve intervention spiral the success of surgery.


First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 105

Your browser does not support the canvas element.


PDF Download: 100

Your browser does not support the canvas element.